|
1
|
Dabestani S, Beisland C, Stewart GD,
Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P,
Marconi L, Fernandéz-Pello S, et al: Intensive imaging-based
follow-up of surgically treated localised renal cell carcinoma does
not improve post-recurrence survival: Results from a European
multicentre database (RECUR). Eur Urol. 75:261–264. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sheth S, Scatarige JC, Horton KM, Corl FM
and Fishman EK: Current concepts in the diagnosis and management of
renal cell carcinoma: Role of multidetector ct and
three-dimensional CT. Radiographics. 21:S237–S254. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vera-Badillo FE, Conde E and Duran I:
Chromophobe renal cell carcinoma: A review of an uncommon entity.
Int J Urol. 19:894–900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Cristofano C, Minervini A, Menicagli M,
Salinitri G, Bertacca G, Pefanis G, Masieri L, Lessi F, Collecchi
P, Minervini R, et al: Nuclear expression of hypoxia-inducible
factor-1alpha in clear cell renal cell carcinoma is involved in
tumor progression. Am J Surg Pathol. 31:1875–1881. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elfiky AA, Aziz SA, Conrad PJ, Siddiqui S,
Hackl W, Maira M, Robert CL and Kluger HM: Characterization and
targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian
target of rapamycin (mTOR) in renal cell cancer. J Transl Med.
9:1332011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shang D, Liu Y, Ito N, Kamoto T and Ogawa
O: Defective Jak- Stat activation in renal cell carcinoma is
associated with interferon-alpha resistance. Cancer Sci.
98:1259–1264. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chappell WH, Steelman LS, Long JM, Kempf
RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone
P, et al: Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors:
Rationale and importance to inhibiting these pathways in human
health. Oncotarget. 2:135–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li M, Wang Y, Song Y, Bu R, Yin B, Fei X,
Guo Q and Wu B: Expression profiling and clinicopathological
significance of DNA methyltransferase 1, 3A and 3B in sporadic
human renal cell carcinoma. Int J Clin Exp Pathol. 7:7597–7609.
2014.PubMed/NCBI
|
|
10
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsiao J, Yuan TY, Tsai MS, Lu CY, Lin YC,
Lee ML, Lin SW, Chang FC, Liu Pimentel H, Olive C, et al:
Upregulation of haploinsufficient gene expression in the brain by
targeting a long non-coding RNA improves seizure phenotype in a
model of Dravet syndrome. EBioMedicine. 9:257–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mills JD, Chen J, Kim WS, Waters PD,
Prabowo AS, Aronica E, Halliday GM and Janitz M: Long intervening
non-coding RNA 00320 is human brain-specific and highly expressed
in the cortical white matter. Neurogenetics. 16:201–213. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Dong M, Fan D, Hou P, Li H, Liu L,
Lin C, Liu J, Su L, Wu L, et al: LncRNA ANCR down-regulation
promotes TGF-β-induced EMT and metastasis in breast cancer.
Oncotarget. 8:67329–67343. 2017.PubMed/NCBI
|
|
15
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
17
|
Vital AL, Tabernero MD, Castrillo A,
Rebelo O, Tao H, Gomes F, Nieto AB, Resende Oliveira C, Lopes MC
and Orfao A: Gene expression profiles of human glioblastomas are
associated with both tumor cytogenetics and histopathology. Neuro
Oncol. 12:991–1003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK,
Ho AS, Lui WM, Fung CF, Wong TS and Leung GK: A long non-coding RNA
signature in glioblastoma multiforme predicts survival. Neurobiol
Dis. 58:123–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amit D, Matouk IJ, Lavon I, Birman T,
Galula J, Abu-Lail R, Schneider T, Siegal T, Hochberg A and Fellig
Y: Transcriptional targeting of glioblastoma by diphtheria toxin-A
driven by both H19 and IGF2-P4 promoters. Int J Clin Exp Med.
5:124–135. 2012.PubMed/NCBI
|
|
20
|
Zhi F, Wang Q, Xue L, Shao N, Wang R, Deng
D, Wang S, Xia X and Yang Y: The use of three long non-coding RNAs
as potential prognostic indicators of astrocytoma. PLoS One.
10:e01352422015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matouk IJ, Mezan S, Mizrahi A, Ohana P,
Abu-Lail R, Fellig Y, Degroot N, Galun E and Hochberg A: The
oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim
Biophys Acta. 1803:443–451. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng M, Blondeau JJ, Schmidt D, Perner S,
Muller SC and Ellinger J: Identification of novel differentially
expressed lncRNA and mRNA transcripts in clear cell renal cell
carcinoma by expression profiling. Genom Data. 5:173–175. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He HT, Xu M, Kuang Y, Han XY, Wang MQ and
Yang Q: Biomarker and competing for endogenous RNA potential of
tumor-specific long noncoding RNA in chromophobe renal cell
carcinoma. Onco Targets Ther. 9:6399–6406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Y, Liu J, Zheng Y, You L, Kuang D and
Liu T: Suppressed expression of long non-coding RNA HOTAIR inhibits
proliferation and tumourigenicity of renal carcinoma cells. Tumour
Biol. 35:11887–11894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Wang T, Li Y, Chen D, Yu Z, Jin L,
Ni L, Yang S, Mao X, Gui Y and Lai Y: Identification of
long-non-coding RNA UCA1 as an oncogene in renal cell carcinoma.
Mol Med Rep. 13:3326–3334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y,
Zhao L, Zhang Y, Huang B and Lu J: LincRNA-ROR induces
epithelial-to-mesenchymal transition and contributes to breast
cancer tumorigenesis and metastasis. Cell Death Dis. 5:e12872014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu T, Chi H, Chen J, Chen C, Huang Y, Xi
H, Xue J and Si Y: Curcumin suppresses proliferation and in vitro
invasion of human prostate cancer stem cells by ceRNA effect of
miR-145 and lncRNA-ROR. Gene. 631:29–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang L, Yu X, Zhang Z, Pang L, Xu J, Jiang
J, Liang W, Chai Y, Hou J and Li F: Linc-ROR promotes esophageal
squamous cell carcinoma progression through the derepression of
SOX9. J Exp Clin Cancer Res. 36:1822017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Shen Z, Zhi Y, Zhou H, Zhang K,
Wang T, Feng B, Chen Y, Song H, Wang R and Chu X: Long non-coding
RNA ROR promotes radioresistance in hepatocelluar carcinoma cells
by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.
Arch Biochem Biophys. 645:117–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi J, Zhang W, Tian H, Zhang Q and Men T:
LncRNA ROR promotes the proliferation of renal cancer and is
negatively associated with favorable prognosis. Mol Med Rep.
16:9561–9566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie H, Fu JL and Xie C: MiR-138-5p is
downregulated in patients with atrial fibrillation and reverses
cardiac fibrotic remodeling via repressing CYP11B2. Eur Rev Med
Pharmacol Sci. 22:4642–4647. 2018.PubMed/NCBI
|
|
32
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang Z, Feng Q, Xu L, Li S and Zhou L:
CREPT regulated by miR-138 promotes breast cancer progression.
Biochem Biophys Res Commun. 493:263–269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Heinemann FG, Tolkach Y, Deng M, Schmidt
D, Perner S, Kristiansen G, Müller SC and Ellinger J: Serum
miR-122-5p and miR-206 expression: Non-invasive prognostic
biomarkers for renal cell carcinoma. Clin Epigenetics. 10:112018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stacker SA and Achen MG: The VEGF
signaling pathway in cancer: The road ahead. Chin J Cancer.
32:297–302. 2013.PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu HB, Chen Q and Ding SQ: LncRNA
LINC01116 competes with miR-145 for the regulation of ESR1
expression in breast cancer. Eur Rev Med Pharmacol Sci.
22:1987–1993. 2018.PubMed/NCBI
|
|
38
|
Zhao L, Han T, Li Y, Sun J, Zhang S, Liu
Y, Shan B, Zheng D and Shi J: The lncRNA SNHG5/miR-32 axis
regulates gastric cancer cell proliferation and migration by
targeting KLF4. FASEB J. 31:893–903. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Q, Gao H, Zhou S and Liao Y: LncRNA
PlncRNA-1 overexpression inhibits the growth of breast cancer by
upregulating TGF-β1 and downregulating PHGDH. Breast Cancer.
25:619–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li P, Tong L, Song Y, Sun J, Shi J, Wu Z,
Diao Y, Li Y and Wang Z: Long noncoding RNA H19 participates in
metformin-mediated inhibition of gastric cancer cell invasion. J
Cell Physiol. 234:4515–4527. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yan J, Zhang Y, She Q, Li X, Peng L, Wang
X, Liu S, Shen X, Zhang W, Dong Y, et al: Long Noncoding RNA
H19/miR-675 axis promotes gastric cancer via FADD/caspase 8/caspase
3 signaling pathway. Cell Physiol Biochem. 42:2364–2376. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lu MH, Tang B, Zeng S, Hu CJ, Xie R, Wu
YY, Wang SM, He FT and Yang SM: Long noncoding RNA BC032469, a
novel competing endogenous RNA, upregulates hTERT expression by
sponging miR-1207-5p and promotes proliferation in gastric cancer.
Oncogene. 35:3524–3534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fei D, Sui G, Lu Y, Tan L, Zhao D and
Zhang K: The long non-coding RNA-ROR promotes osteosarcoma
progression by targeting miR-206. J Cell Mol Med. 23:1865–1872.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kyzas PA, Cunha IW and Ioannidis JP:
Prognostic significance of vascular endothelial growth factor
immunohistochemical expression in head and neck squamous cell
carcinoma: A metaanalysis. Clin Cancer Res. 11:1434–1440. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang T, Liu M, Wang C, Lin C, Sun Y and
Jin D: Down-regulation of miR-206 promotes proliferation and
invasion of laryngeal cancer by regulating VEGF expression.
Anticancer Res. 31:3859–3863. 2011.PubMed/NCBI
|
|
46
|
Liang Z, Bian X and Shim H: Downregulation
of microRNA-206 promotes invasion and angiogenesis of triple
negative breast cancer. Biochem Biophys Res Commun. 477:461–466.
2016. View Article : Google Scholar : PubMed/NCBI
|
